Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8609) 8609
Publication (1184) 1184
Book Chapter (68) 68
Book Review (55) 55
Dissertation (30) 30
Conference Proceeding (18) 18
Government Document (7) 7
Web Resource (2) 2
Book / eBook (1) 1
Magazine Article (1) 1
Newspaper Article (1) 1
Reference (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5693) 5693
c-met (4505) 4505
index medicus (4016) 4016
animals (3303) 3303
oncology (2904) 2904
proto-oncogene proteins c-met - metabolism (2595) 2595
female (2128) 2128
male (1930) 1930
mice (1924) 1924
cancer (1859) 1859
expression (1850) 1850
proto-oncogene proteins c-met - genetics (1843) 1843
hepatocyte growth-factor (1736) 1736
cell line, tumor (1544) 1544
cell biology (1388) 1388
hepatocyte growth factor (1317) 1317
signal transduction (1278) 1278
biochemistry & molecular biology (1236) 1236
hepatocyte growth factor - metabolism (1181) 1181
middle aged (1159) 1159
metastasis (1074) 1074
aged (1007) 1007
phosphorylation (960) 960
proto-oncogene proteins c-met - antagonists & inhibitors (920) 920
adult (913) 913
met (913) 913
immunohistochemistry (888) 888
tumors (870) 870
receptor (865) 865
gene expression (790) 790
mutation (790) 790
hepatocyte growth factor - pharmacology (757) 757
tyrosine kinase (754) 754
kinases (750) 750
research (740) 740
prognosis (715) 715
apoptosis (700) 700
activation (696) 696
proto-oncogene proteins c-met (696) 696
factor scatter factor (694) 694
hgf (691) 691
c-met protein (681) 681
scatter factor (669) 669
hepatocyte growth factor - genetics (667) 667
analysis (663) 663
tyrosine (646) 646
proteins (636) 636
receptor tyrosine kinase (628) 628
article (623) 623
rats (616) 616
cell proliferation (614) 614
gene expression regulation, neoplastic (609) 609
cells (601) 601
antineoplastic agents - pharmacology (579) 579
growth factors (572) 572
cells, cultured (567) 567
genetic aspects (559) 559
cell proliferation - drug effects (539) 539
epithelial-cells (528) 528
protein kinase inhibitors - pharmacology (527) 527
signal transduction - drug effects (527) 527
tumor cells, cultured (525) 525
aged, 80 and over (494) 494
growth (494) 494
angiogenesis (491) 491
lung cancer (483) 483
growth-factor receptor (473) 473
blotting, western (469) 469
cell line (463) 463
health aspects (460) 460
mice, nude (457) 457
lung neoplasms - genetics (454) 454
care and treatment (452) 452
carcinoma (450) 450
hepatocyte growth factor - physiology (444) 444
pathology (443) 443
amplification (421) 421
identification (420) 420
in-vitro (420) 420
antineoplastic agents - therapeutic use (414) 414
invasion (412) 412
neoplasm invasiveness (409) 409
gene (408) 408
research article (407) 407
medicine, research & experimental (403) 403
xenograft model antitumor assays (400) 400
chemotherapy (397) 397
lung-cancer (392) 392
survival (389) 389
factor receptor (387) 387
lung neoplasms - pathology (386) 386
proliferation (385) 385
cell lung-cancer (383) 383
down-regulation (383) 383
gene amplification (382) 382
reverse transcriptase polymerase chain reaction (382) 382
lung neoplasms - drug therapy (380) 380
overexpression (377) 377
multidisciplinary sciences (372) 372
development and progression (370) 370
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8414) 8414
Chinese (118) 118
French (43) 43
Japanese (41) 41
Korean (23) 23
German (21) 21
Spanish (15) 15
Russian (8) 8
Hungarian (6) 6
Polish (4) 4
Italian (2) 2
Czech (1) 1
Portuguese (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. c-MET and KRAS: Signalling and Clinical Implications in Colorectal Cancer
by Organ, Shawna L
11/2013
Colorectal cancer (CRC) is the third leading cause of death from cancer in North America. The KRAS gene is mutated in approximately 40-50% of all CRC, and this... 
0379 | c-MET | KRAS
Dissertation
Details down arrow
2. Full Text Quercetin inhibits HGF/c-Met signaling and HGFstimulated melanoma cell migration and invasion
by Cao, Hui-Hui and Cheng, Chi-Yan and Su, Tao and Fu, Xiu-Qiong and Guo, Hui and Li, Ting and Tse, Anfernee Kai-Wing and Kwan, Hiu-Yee and Yu, Hua and Yu, Zhi-Ling
Molecular Cancer, 05/2015, Volume 14, Issue 1
Metastasis | Migration | Invasion | C-Met | Melanoma | Quercetin
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Ligand-independent activation of c-Met by fibronectin and α5 Β1-integrin regulates ovarian cancer invasion and metastasis
by Mitra, A.K and Sawada, K and Tiwari, P and Mui, K and Gwin, K and Lengyel, E
Oncogene, ISSN 0950-9232, 03/2011, Volume 30, Issue 13, pp. 1566 - 1576
α | FAK | β | fibronectin | ovarian cancer | Src | c-Met | integrin
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Triazolopyridazine derivatives: Synthesis, cytotoxic evaluation, c-Met kinase activity and molecular docking
by Ahmed, Eman M and Khalil, Nadia A and Taher, Azza T and Refaey, Rana H and Nissan, Yassin M
Bioorganic Chemistry, ISSN 0045-2068, 11/2019, Volume 92, p. 103272
Novel series of some triazolo[4,3- ]pyridazine derivatives were designed and synthesized. All the newly synthesized compounds were evaluated for their... 
Pyridazines | Triazolopyridazines | Cytotoxic activity | c-Met kinase
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Loss of c-Met accelerates development of liver fibrosis in response to CCl 4 exposure through deregulation of multiple molecular pathways
by Marquardt, Jens U and Seo, Daekwan and Gómez-Quiroz, Luis E and Uchida, Koichi and Gillen, Matthew C and Kitade, Mitsuteru and Kaposi-Novak, Pal and Conner, Elizabeth A and Factor, Valentina M and Thorgeirsson, Snorri S
Biochimica et Biophysica Acta - Molecular Basis of Disease, ISSN 0925-4439, 06/2012, Volume 1822, Issue 6, pp. 942 - 951
HGF/c-Met signaling plays a pivotal role in hepatocyte survival and tissue remodeling during liver regeneration. HGF treatment accelerates resolution of... 
C-met | Fibrosis | Microarray | CCl
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis
by Zhang, Haiyang and Deng, Ting and Liu, Rui and Bai, Ming and Zhou, Likun and Wang, Xia and Li, Shuang and Wang, Xinyi and Yang, Haiou and Li, Jialu and Ning, Tao and Huang, DIngzhi and Li, Hongli and Zhang, Le and Ying, Guoguang and Ba, Yi
Nature Communications, ISSN 2041-1723, 04/2017, Volume 8, Issue 1, p. 15016
The metastatic organotropism has been one of the cancer's greatest mysteries since the 'seed and soil' hypothesis. Although the role of EGFR in cancer cells is... 
MELANOMA EXOSOMES | SERUM-LEVEL | MULTIDISCIPLINARY SCIENCES | HEPATOCYTE GROWTH-FACTOR | PANCREATIC-CANCER | C-MET | MICROVESICLES | MEDIATED TRANSFER | TUMOR-GROWTH | TUMORIGENESIS | T-CELLS
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-κB signalling
by Studer, Lorenz and Socci, Nicholas D and Scher, Howard I and Gerald, William and Rajasekhar, Vinagolu K
Nature Communications, ISSN 2041-1723, 01/2011, Volume 2, Issue 1, p. 162
Androgen depletion is a key strategy for treating human prostate cancer, but the presence of hormone-independent cells escaping treatment remains a major... 
ANDROGEN RECEPTOR | ORIGIN | INTERMEDIATE CELLS | EPITHELIAL-CELLS | MULTIDISCIPLINARY SCIENCES | IN-VIVO | C-MET | MODEL | EXPRESSION | CARCINOMA | BASAL-CELLS
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text The long non-coding RNA NEAT1 enhances epithelial-tomesenchymal transition and chemoresistance via the miR-34a/ c-Met axis in renal cell carcinoma
by Liu, Fei and Chen, Na and Gong, Yanchun and Xiao, Ruihai and Wang, Weichao and Pan, Zhengyue
Oncotarget, 2017, Volume 8, Issue 38, pp. 62927 - 62938
Chemotherapy | MiR-34a | NEAT1 | Renal cell carcinoma | C-Met
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Loss of E-cadherin promotes ovarian cancer metastasis via alpha(5)-integrin, which is a therapeutic target
by Sawada, K and Mitra, AK and Radjabi, AR and Bhaskar, V and Kistner, EO and Tretiakova, M and Jagadeeswaran, S and Montag, A and Becker, A and Kenny, HA and Peter, ME and Ramakrishnan, V and Yamada, SD and Lengyel, E
CANCER RESEARCH, ISSN 0008-5472, 04/2008, Volume 68, Issue 7, pp. 2329 - 2339
E-cadherin loss is frequently associated with ovarian cancer metastasis. Given that adhesion to the abdominal peritoneum is the first step in ovarian cancer... 
HUMAN MESOTHELIAL CELLS | ADHESION | IN-VITRO | INVASION | PROGNOSTIC-FACTOR | ONCOLOGY | C-MET OVEREXPRESSION | ACTIVATOR RECEPTOR EXPRESSION | INTEGRIN | TUMOR-CELLS | CARCINOMA
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Preliminary application of micro-SPECT/CT imaging by 99m Tc-tricine-EDDA-HYNIC-c-Met for non-small-cell lung cancer
by Zhang, Yiqiu and Meng, Lanfang and Li, Beilei and Tan, Hui and Lin, Qing-Yu and Cheng, Dengfeng and Shi, Hongcheng
Chemical Biology and Drug Design, ISSN 1747-0277, 04/2019, Volume 93, Issue 4, pp. 447 - 453
A novel Tc-tricine-EDDA-Hynic-c-Met molecular probe was synthetized, and nude mice models of human non-small-cell lung cancer (NSCLC) were established in order... 
micro-SPECT/CT | c-Met | non-small-cell lung cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Failures in preclinical and clinical trials of c-Met inhibitors: Evaluation of pathway activity as a promising selection criterion
by Hughes, Veronica S and Siemann, Dietmar W
Oncotarget, ISSN 1949-2553, 01/2019, Volume 10, Issue 2, pp. 184 - 197
C-Met is a frequently overexpressed or amplified receptor tyrosine kinase involved in metastatic-related functions, including migration, invasion, cell... 
Microenvironment | Small molecule inhibitor | HGF | C-Met | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Discovery of an Indirubin Derivative as a Novel c-Met Kinase Inhibitor with In Vitro Anti-Tumor Effects
by Karyn Muzinga Ndolo and and Su Jin An and Kyeong Ryang Park and Hyo Jeong Lee and Kyoung Bin Yoon and Yong-chul Kim and Sun-young Han
Biomolecules & Therapeutics(구 응용약물학회지), ISSN 1976-9148, 2019, Volume 27, Issue 2, pp. 216 - 221
The c-Met protein is a receptor tyrosine kinase involved in cell growth, proliferation, survival, and angiogenesis of several human tumors. Overexpression of... 
c-Met | Indirubin | Gastric cancer | LDD-1937
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Prognostic value of c-Met in colorectal cancer:A metaanalysis
by Yan Liu Xiao-Feng Yu Jian Zou Zi-Hua Luo
世界胃肠病学杂志：英文版, ISSN 1007-9327, 2015, Issue 12, pp. 3706 - 3710
AIM: To assess the prognostic value of c-Met status in colorectal cancer. METHODS: We conducted a search in Pub Med, Web of Science, and the Cochrane Library... 
Colorectal | cancer;Prognosis;c-Met;Metaanalysis;Ove
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Discovery of Selective Matriptase and Hepsin Serine Protease Inhibitors: Useful Chemical Tools for Cancer Cell Biology
by Damalanka, Vishnu C and Han, Zhenfu and Karmakar, Partha and O'Donoghue, Anthony J and La Greca, Florencia and Kim, Tommy and Pant, Shishir M and Helander, Jonathan and Klefström, Juha and Craik, Charles S and Janetka, James W
Journal of Medicinal Chemistry, ISSN 0022-2623, 01/2019, Volume 62, Issue 2, pp. 480 - 490
Matriptase and hepsin belong to the family of type II transmembrane serine proteases (TTSPs). Increased activity of these and the plasma protease, hepatocyte... 
RON | PROSTATE | DESIGN | CHEMISTRY, MEDICINAL | PATHWAY | HEPATOCYTE GROWTH-FACTOR | C-MET | FACTOR ACTIVATION | RESISTANCE | EXPRESSION | PROGRESSION
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Discovery of Potent, Selective, and Brain-Penetrant 1H-Pyrazol-5-yl-1H-pyrrolo[2,3-b]pyridines as Anaplastic Lymphoma Kinase (ALK) Inhibitors
by Fushimi, M and Fujimori, I and Wakabayashi, T and Hasui, T and Kawakita, Y and Imamura, K and Kato, T and Murakami, M and Ishii, T and Kikko, Y and Kasahara, M and Nakatani, A and Hiura, Y and Miyamoto, M and Saikatendu, K and Zou, H and Lane, SW and Lawson, JD and Imoto, H
JOURNAL OF MEDICINAL CHEMISTRY, ISSN 0022-2623, 05/2019, Volume 62, Issue 10, pp. 4915 - 4935
Anaplastic lymphoma kinase (ALK), a member of the receptor tyrosine kinase family, is predominantly expressed in the brain and implicated in neuronal... 
REFINEMENT | TRANSPORT | DESIGN | IMPACT | CHEMISTRY, MEDICINAL | C-MET | BARRIER | PROLIFERATION | PF-2341066 | RECEPTOR TYROSINE KINASE | P-GLYCOPROTEIN
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text A Phase 1 Study of the c-Met Inhibitor, Tivantinib (ARQ197) in Children with Relapsed or Refractory Solid Tumors: A Children’s Oncology Group Study Phase 1 and Pilot Consortium Trial (ADVL1111)
by Geller, James I and Perentesis, John P and Liu, Xiaowei and Minard, Charles G and Kudgus, Rachel A and Reid, Joel M and Fox, Elizabeth and Blaney, Susan M and Weigel, Brenda J
Pediatric blood & cancer, ISSN 1545-5009, 11/2017, Volume 64, Issue 11
c-Met | phase I | tivantinib | pediatric solid tumor
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Full Text 1,2,4-Oxadiazole derivatives targeting EGFR and c-Met degradation in TKI resistant NSCLC
by Dokla, Eman M.E and Fang, Chun-Sheng and Abouzid, Khaled A.M and Chen, Ching S
European Journal of Medicinal Chemistry, ISSN 0223-5234, 11/2019, Volume 182, p. 111607
Development of small-molecule agents with the ability to facilitate oncoprotein degradation has emerged as a promising strategy for cancer therapy. Since EGFR... 
Oncoprotein degradation | 1,2,4-Oxadiazoles | c-Met | TKI resistant NSCLC | EGFR
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
18. Full Text The miR-34 family in cancer and apoptosis
by Hermeking, H
Cell Death and Differentiation, ISSN 1350-9047, 02/2010, Volume 17, Issue 2, pp. 193 - 199
Recently, the transcription factor encoded by tumor suppressor gene p53 was shown to regulate the expression of microRNAs. The most significant induction by... 
MiR-34 | MicroRNA | MiR-34a | SIRT1 | MiR-34b/c | TARGET | RNA | miR-34a | BIOCHEMISTRY & MOLECULAR BIOLOGY | DOWN-REGULATION | TRANSCRIPTIONAL REPRESSION | CELL-PROLIFERATION | p53 | CELL BIOLOGY | miR-34b/c | GENE | miR-34 | COLORECTAL-CANCER | C-MET | microRNA | P53 TUMOR-SUPPRESSOR | MICRORNA EXPRESSION | Neoplasms - genetics | Humans | Gene Expression Regulation, Neoplastic | MicroRNAs - genetics | Apoptosis - physiology | Neoplasms - pathology | Tumor Suppressor Protein p53 - genetics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
19. Full Text Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
by Peinado, Héctor and Alečković, Maša and Lavotshkin, Simon and Matei, Irina and Costa-Silva, Bruno and Moreno-Bueno, Gema and Hergueta-Redondo, Marta and Williams, Caitlin and García-Santos, Guillermo and Ghajar, Cyrus M and Nitadori-Hoshino, Ayuko and Hoffman, Caitlin and Badal, Karen and Garcia, Benjamin A and Callahan, Margaret K and Yuan, Jianda and Martins, Vilma R and Skog, Johan and Kaplan, Rosandra N and Brady, Mary S and Wolchok, Jedd D and Chapman, Paul B and Kang, Yibin and Bromberg, Jacqueline and Lyden, David
Nature Medicine, ISSN 1078-8956, 06/2012, Volume 18, Issue 6, pp. 883 - 891
Tumor-derived exosomes are emerging mediators of tumorigenesis. We explored the function of melanoma-derived exosomes in the formation of primary tumors and... 
MEDICINE, RESEARCH & EXPERIMENTAL | RECRUITMENT | MECHANISM | BIOCHEMISTRY & MOLECULAR BIOLOGY | MICROVESICLES | CANCER | CELL BIOLOGY | SIGNALING PATHWAY | PREMETASTATIC NICHE | RELEASED EXOSOMES | C-MET | GROWTH | EXPRESSION | Cell Line | Prognosis | Humans | Mice, Inbred C57BL | Bone Marrow Cells - physiology | Melanoma - pathology | Melanoma - secondary | Phenotype | Proto-Oncogene Proteins c-met - physiology | rab GTP-Binding Proteins - physiology | Animals | Exosomes - physiology | rab27 GTP-Binding Proteins | Female | Stem Cells - physiology | Mice | Physiological aspects | Development and progression | Cell organelles | B cells | Research | Melanoma | Bone marrow | Genotype & phenotype | Metastasis | Stem cells | Tumors | Skin cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
20. Full Text Opinion - Invasive growth: a MET-driven genetic programme for cancer and stem cells
by Boccaccio, C and Comoglio, PM
NATURE REVIEWS CANCER, ISSN 1474-175X, 08/2006, Volume 6, Issue 8, pp. 637 - 645
Metastasis follows the inappropriate activation of a genetic programme termed invasive growth, which is a physiological process that occurs during embryonic... 
EPITHELIAL-MESENCHYMAL TRANSITION | HUMAN BREAST-CARCINOMA | TUMOR PROGRESSION | ONCOLOGY | FACTOR SCATTER FACTOR | C-MET | BONE-MARROW | ACUTE MYELOID-LEUKEMIA | RECEPTOR TYROSINE KINASE | HGF RECEPTOR | FACTOR/SCATTER FACTOR
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.